| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Stress Protein Group, Joint Center for Radiation Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts 02115
2 To whom requests for reprints should be addressed, at Joint Center for Radiation Therapy, 50 Binney St., Boston, MA 02115.
Damage to chromosomal DNA increases the levels of the transcriptional regulatory protein p53. We have investigated how the MDM2 protein, which binds to p53 and inactivates its transcriptional activity, may be controlled following DNA damage. Irradiation of human GM2149 fibroblast cells causes an increase in MDM2 mRNA levels within 1 h, and levels remain elevated for at least 8 h. The induction of MDM2 mRNA following irradiation is not blocked by inhibitors of protein synthesis and can be detected after doses of 2-5 Gy. In ataxia telangiectasia cells or cells where p53 is mutated/deleted, MDM2 mRNA levels are not increased after DNA damage. This suggests that p53 is required for transcription of the MDM2 gene following DNA damage.
1 Supported by funds from the Joint Center for Radiation Therapy.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 11/17/93. Accepted 1/ 5/94.
This article has been cited by other articles:
![]() |
S. P. Deb Cell Cycle Regulatory Functions of the Human Oncoprotein MDM2 Mol. Cancer Res., December 1, 2003; 1(14): 1009 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Wani, Q. Zhu, M. El-Mahdy, S. Venkatachalam, and A. A. Wani Enhanced Sensitivity to anti-Benzo(a)pyrene-diol-epoxide DNA Damage Correlates with Decreased Global Genomic Repair Attributable to Abrogated p53 Function in Human Cells Cancer Res., April 1, 2000; 60(8): 2273 - 2280. [Abstract] [Full Text] |
||||
![]() |
M. Urashima, G. Teoh, D. Chauhan, A. Ogata, S. Shirahama, C. Kaihara, M. Matsuzaki, H. Matsushima, M. Akiyama, Y. Yuza, et al. MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor-Dependent Acute Myeloblastic Leukemia Cells Blood, August 1, 1998; 92(3): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perz and J. G. Kuhn Review : p53 in the pathogenesis, diagnosis, and treatment of cancer Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102. [Abstract] [PDF] |
||||
![]() |
T. Leveillard and B. Wasylyk The MDM2 C-terminal Region Binds to TAFII250 and Is Required for MDM2 Regulation of the Cyclin A Promoter J. Biol. Chem., December 5, 1997; 272(49): 30651 - 30661. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Teoh, M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells Blood, September 1, 1997; 90(5): 1982 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Jones, A. T. Sands, A. R. Hancock, H. Vogel, L. A. Donehower, S. P. Linke, G. M. Wahl, and A. Bradley The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2 PNAS, November 26, 1996; 93(24): 14106 - 14111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Beamish, R. Williams, P. Chen, and M. F. Lavin Defect in Multiple Cell Cycle Checkpoints in Ataxia-Telangiectasia Postirradiation J. Biol. Chem., August 23, 1996; 271(34): 20486 - 20493. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hartwell and M. Kastan Cell cycle control and cancer Science, December 16, 1994; 266(5192): 1821 - 1828. [Abstract] [PDF] |
||||
![]() |
A Di Leonardo, S P Linke, K Clarkin, and G M Wahl DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes & Dev., November 1, 1994; 8(21): 2540 - 2551. [Abstract] [PDF] |
||||
![]() |
A. Hsing, D. V. Faller, and C. Vaziri DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms J. Biol. Chem., August 18, 2000; 275(34): 26024 - 26031. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |